![Darin Lippoldt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Darin Lippoldt
President på
SOLENO THERAPEUTICS, INC.
Förmögenhet: 9 M $ per 2026-06-30
Profil
Darin Michael Lippoldt is currently President, Secretary & Director at Soleno Therapeutics, Inc. since 2026.
He is also Director at Immedica Group Ltd. since 2022 and Secretary & Chief Legal Officer at Neurocrine Biosciences, Inc. since 2014.
Formerly, Mr. Lippoldt was Associate General Counsel at Amylin Pharmaceuticals, Inc. from 2003 to 2010.
From 2013 to 2014, served as Secretary, Chief Compliance Officer & Executive VP at Philips Image Guided Therapy Corp.
Education includes undergraduate and graduate degrees from St. Mary's University, with the undergraduate degree conferred in 1987.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-09 | 54 729 ( 0,05 % ) | 9 M $ | 2026-06-30 |
Aktiva positioner av Darin Lippoldt
| Företag | Position | Start |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Generell Rådgivare | 2014-10-01 |
| DIUL GROUP | Direktör/Styrelseledamot | 2022-11-01 |
| SOLENO THERAPEUTICS, INC. | President | 2026-05-15 |
Tidigare kända positioner av Darin Lippoldt
| Företag | Position | Slut |
|---|---|---|
| VOLCANO CORPORATION | Compliance Officer | 2014-10-01 |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Företagsledare/Principal | 2010-07-01 |
Darin Lippoldts utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
65
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Philips Image Guided Therapy Corp.
 Philips Image Guided Therapy Corp. Medical SpecialtiesHealth Technology Designs, develops and manufactures intravascular ultrasound products | Health Technology |
Soleno Therapeutics, Inc.
 Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
St. Mary's University
 St. Mary's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Diurnal Group Ltd.
 Diurnal Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and commercializes therapeutics for neuropsychiatric, neurological & neuroendocrine disorders | Health Technology |
